An impressive array of new automated analyzers for central diagnostic laboratories was unveiled at a recent lab equipment trade fair.

The IFCC WorldLab exposition held June 22-26, 2014, in Istanbul (Turkey) was the venue chosen by Siemens Healthcare (Erlangen, Germany) to introduce several new or upgraded analytical diagnostic systems.

The "heavyweights" showcased at the exhibits were two central laboratory clinical analyzers, the ADVIA Chemistry XPT System and the ADVIA Centaur XPT Immunoassay System. These new clinical systems were designed to enhance workflow and streamline processes to quickly, reliably, and cost-effectively meet ever-increasing workload demands. Both systems offer new user interfaces, large touch screens, and remote service diagnostics, and each system features versatile technology enabling a broad range of testing that supports clinicians in the screening, diagnosing, and monitoring of even the most complex diseases.

Both the ADVIA Chemistry XPT System and the ADVIA Centaur XPT Immunoassay System have enhanced data management capability with the Siemens CentraLink Data Management System, which is linked to Aptio Automation, the latest track-based automation system.

The CentraLink Data Management System Version 15, with optional Advanced Hematology Module enables laboratories to automate their hematology workflow, which reduces manual steps and increases efficiency. Furthermore, new software incorporated in the RAPIDComm Data Management System now supports the new RAPIDComm Web Application, which allows point-of-care coordinators, via a handheld device, to view instrument status, troubleshoot issues, and remotely manage blood gas instruments.

Also on display at IFCC WorldLab was the RAPIDLab 348EX Blood Gas System, a cost-effective solution for the measurement of pH, oxygen, carbon dioxide, electrolytes, and hematocrit designed for the low-volume laboratory settings. The RAPIDLab 348EX Blood Gas System accurately delivers actionable patient test results in approximately 60 seconds on as little as 50 microliters of whole blood.

"At Siemens, we understand the critical role that in vitro diagnostic (IVD) testing plays in the lives of patients and their families," said Michael Reitermann, CEO of Siemens Healthcare's diagnostics division. "This year's IFCC WorldLab provides an excellent platform to demonstrate how our products and services, regardless of where testing takes place, deliver clinical excellence and workflow solutions that can ultimately enable better patient care."

Related Links:
Siemens Healthcare